Edwards Lifesciences Corporation (NYSE: EW) entered into an accelerated share repurchase (ASR) agreement to repurchase an aggregate of $400 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE